logo
Already a customer? Click on the Help Portal below to login to your account.
Help Portal

We're social! Follow us on LinkedIn and Twitter to stay on top of the latest VoicePort technology and innovation news.

innovative solutions Tag

New Vaccination Guidelines, New Opportunity

Time to roll up the sleeves-again. Last week the FDA, acting on the recommendation from the CDC’s Advisory Committee for Immunization Practices (ACIP), gave its approval to GSK to market Shingrix® to prevent shingles. The new guidance is based on a vaccine initially developed at the University of Colorado Health Sciences Center, now the University of Colorado Anschutz Medical Campus. Widespread risk More than 99% of those older than 50 years are infected with Varicella Zoster Virus, and one in three Americans will develop shingles in their lifetime. The new recommendations apply to adults over the age of 50 including those previously received Zostavax®. "The...

Read More